Core Insights - Ocumetics Technology Corp. has completed one-month postoperative examinations of the first patients implanted with the Ocumetics Accommodating Intraocular Lens in Mexico City on August 15, 2025 [1][2] - The company is currently focusing on Group 1 patients, with surgeries for the second and final day scheduled for September 24, 2025 [3] - The clinical protocol is designed to evaluate safety, distance vision correction, product handling, and near reading ability [7] Company Overview - Ocumetics Technology Corp. is a Canadian research and product development company dedicated to advanced vision correction solutions aimed at enhancing patient quality of life [4] - The company is in the preclinical study phase of a new intraocular lens technology that may eliminate the need for corrective lenses by allowing natural muscle activity to shift focus [5]
Ocumetics Completes One-Month Postoperative Examinations - Results Pending
Thenewswire·2025-09-16 13:00